up 2 cents to over $42 and you predicted sub $30 LOL @ you.
treword77 • Nov 14, 2015 10:34 AM
.....by Friday? tia
no. they missed it already, T is up. Over valued @ $42. buy here, you get 4.57% div. And a pps that could easily go under $40 without a solid CC and an increase in revenue going forward out to 2020.
"idiots like me" LOL. If you say so :)
Tue Aug 25 15:59:31 2015 Buy T Executed @ $31.79
Fri Nov 13 14:10:02 2015 Buy T Executed @ $32.49
Without an announced increase in earnings, T is over valued at $42.
Are you kidding? those loafers love being in a union where they benefit from others working
but this time I do agree with him. Why would I buy vz here when I bought it jan 20 at 43.95? for me it is too expensive but if you're a long long holder, 4.1% div won't hurt you.
yes and utilities are too high to buy now :(
all up too high to buy IMO
Someone knocked our robot Carolyn but she's right, 3 days after I said it but she's also right. T is over valued at $42
On 6/24/16, T announced a regular quarterly cash dividend of $0.48 per share, payable on 8/1/16 to shareholders, with an ex-dividend date of 7/6/16
and in December it goes to .49 :)
more fear (brexit) is driving more buyers to T but T is overvalued. Without a co. stated increase in earnings. CC should be interesting. $42 now. Overvalued. Anyone not a true long should take it and thank the Brits
Maybe the Chairman agrees with you? Nice move to see, eh?
Celgene Corporation (NASDAQ: CELG) had one of the top executives selling shares last week. Robert Hugin, who is the Executive Chairman at the biotech giant sold a total of 75,000 shares of the stock at a price of $100.16. The total for the sale was posted at $7,512,000. The company discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. The shares closed the day Friday at $100.66